Early Drug Development Decision-Making Tips
Effects of Excipients on Skin Delivery of Drugs and Actives
Subcutaneous Drug Delivery
Data as cGMP Records and Other Integrity Issues
Data Integrity Challenges
Maximizing the Effectiveness of Softgels Part 2
Maximizing the Effectiveness of Softgels Part 1
Sourcing APIs and Supply Chain Management
Accelerating the Pathways to Biologics, Part 2
Accelerating the Pathways to Biologics, Part 1
Lipid Formulations for Drug Development
Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 3
Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 2
Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 1
Strategies for Improving Preclinical Drug Development
Lonza AAPS Videos
Use of Extractables Data from Single-Use Components for Risk Assessments
Transforming Clinical Trials with Smart Technologies
Thought Leadership Series: Analytical Bioassay Cell Banking
ShinEtsu Video Page
Catalent Dose Design
BASF Solubility Challenges
Thought Leadership Series: Solubilization
Catalent Small Molecule
Catalent Early Development
Catalent Clinical Supply
BASF Solubility
Formulation Trends for Topical Dosage Forms Part 2
Formulation Trends for Topical Dosage Forms
